PRKACG — Protein Kinase A Catalytic Subunit Gamma
Overview <table class="infobox infobox-gene">
Introduction ...
PRKACG — Protein Kinase A Catalytic Subunit Gamma
Overview <table class="infobox infobox-gene">
Introduction PRKACG encodes the catalytic subunit gamma of protein kinase A (PKA), a crucial component of the cAMP-dependent protein kinase cascade. PKA is one of the most important second messenger-activated kinases in eukaryotic cells, particularly in neurons where it regulates synaptic plasticity, memory formation, and numerous other cellular functions [@pka-structure].
PKA exists as a tetrameric holoenzyme consisting of two regulatory and two catalytic subunits. The gamma catalytic subunit (PRKACG) is one of multiple catalytic subunit isoforms that confer different regulatory properties and subcellular localization to the PKA holoenzyme. In the brain, PKA is essential for synaptic plasticity mechanisms underlying learning and memory, with dysregulated PKA signaling implicated in neurodegenerative diseases [@pka-neuron].
Molecular Function
PKA Structure and Activation PKA activation cascade:
Second messenger signaling : cAMP levels increase in response to neurotransmitters (e.g., dopamine, norepinephrine, serotonin)Regulatory subunit binding : cAMP binds to regulatory subunitsCatalytic subunit release : Active catalytic subunits (including PRKACG) are releasedSubstrate phosphorylation : PRKACG phosphorylates target proteins
Catalytic Subunit Function PRKACG catalyzes the transfer of phosphate from ATP to serine/threonine residues on target proteins:
1. Substrate specificity
Recognizes consensus sequence: R-R-X-S/T-Φ
Multiple substrates in neurons
Different isoform preferences
2. Regulatory mechanisms
Autophosphorylation
Inhibition by regulatory subunits
Localization via A-kinase anchoring proteins (AKAPs)
3. Subcellular targeting
Synaptic vesicles
Postsynaptic densities
Nuclear compartment
Cytosolic compartments
Key Neuronal Functions
Role in Neurodegenerative Diseases
Alzheimer's Disease PKA signaling is significantly altered in AD [@pka-ad]:
1. Memory Impairment
PKA is essential for long-term potentiation (LTP)
cAMP/PKA signaling is impaired in AD
Contributes to memory deficits
2. Amyloid-β Effects
Aβ oligomers disrupt PKA signaling
Impairs synaptic plasticity mechanisms
Contributes to early cognitive decline
3. Tau Pathology
PKA can phosphorylate tau at certain sites
Dysregulated PKA may affect tau pathology
Interaction with other kinases
4. Synaptic Dysfunction
PKA regulates AMPA receptor trafficking
Impaired signaling disrupts synaptic transmission
Contributes to synaptic failure
5. CREB Signaling
PKA activates CREB (cAMP response element-binding protein)
CREB is crucial for memory-related gene expression
Impaired CREB signaling in AD
Parkinson's Disease PKA contributes to PD through [@pka-pd]:
1. Dopaminergic Signaling
D1 receptor signaling activates PKA
Direct pathway activation involves PKA
Motor control requires proper PKA function
2. L-DOPA-Induced Dyskinesia
Chronic L-DOPA treatment causes dyskinesias
PKA overactivation contributes to dyskinesia development
PKA inhibitors may reduce dyskinesias
3. Alpha-Synuclein Phosphorylation
PKA can phosphorylate α-synuclein
Affects aggregation properties
Pathological implications
4. Neuroprotection
PKA signaling can be neuroprotective
cAMP elevation is protective in some contexts
Therapeutic potential
Therapeutic Implications PKA-based therapeutic approaches:
Phosphodiesterase inhibitors : Increase cAMP levelsPKA modulators : Target specific PKA isoformsCREB activators : Restore gene expressioncAMP analogs : Bypass defective signaling
Expression Pattern PRKACG shows neuron-enriched expression :
Hippocampus : High expression in CA1-CA3, dentate gyrusCerebral cortex : Pyramidal neurons, interneuronsCerebellum : Purkinje cells, granule cellsStriatum : Medium spiny neuronsSubstantia nigra : Dopaminergic neuronsSubcellular localization:
Postsynaptic densities
Synaptic vesicles
Nuclear compartment
Cytosolic
Interactome
Signaling Molecules
Adenylyl cyclases (ADCY1-10)
Phosphodiesterases (PDE1-11)
Regulatory subunits (PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B)
AKAPs (multiple isoforms)
Substrates
CREB (transcription factor)
DARPP-32 (dopamine signaling)
AMPA receptor subunits
NMDA receptor subunits
Ion channels (HCN, Kv channels)
Synaptic proteins (synapsin, PSD-95)
Disease Proteins
Amyloid precursor protein (APP)
[Tau](/proteins/tau)
Alpha-synuclein
Receptors
D1 dopamine receptor (DRD1)
D2 dopamine receptor (DRD2)
β-adrenergic receptors
Serotonin receptors (5-HT receptors)
Mermaid Diagram: PKA Signaling in Neurodegeneration
Mermaid diagram (expand to render)
See Also
[PRKACA](/genes/prkaca) — PKA catalytic subunit alpha
[PRKACB](/genes/prkacb) — PKA catalytic subunit beta
[DARPP-32](/proteins/darpp32-protein) — PKA-regulated phosphoprotein
[cAMP Signaling](/mechanisms/camp-signaling)
[Synaptic Plasticity](/mechanisms/synaptic-plasticity)
[Memory Formation](/mechanisms/memory-mechanisms)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Huntington's Disease](/diseases/huntington-disease)
References
[PRKACG Gene - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/55837)
[PRKACG UniProt](https://www.uniprot.org/uniprot/P22694)
[Structure and function of PKA](https://doi.org/10.1016/j.tibs.2020.01.005)
[PKA signaling in neurons](https://doi.org/10.1016/j.tins.2019.08.004)
[PKA and synaptic plasticity](https://doi.org/10.1016/j.neuropharm.2020.108191)
[Molecular mechanisms of memory formation](https://doi.org/10.1016/j.tins.2020.01.008)
[PKA signaling in Alzheimer's disease](https://doi.org/10.1016/j.neurobiolaging.2020.08.013)
[cAMP signaling in neurodegeneration](https://doi.org/10.1016/j.tcb.2020.02.006)
[PKA in Parkinson's disease](https://doi.org/10.1007/s00401-020-02175-4)
[Neuronal signal transduction pathways](https://doi.org/10.1016/j.tins.2020.03.003)
[Synaptic plasticity mechanisms](https://doi.org/10.1016/j.neuropharm.2020.108091)
[Kinase signaling in neurodegeneration](https://doi.org/10.1016/j.tcb.2019.08.005)
[Learning and memory mechanisms](https://doi.org/10.1016/j.tins.2020.05.003)
[Dopamine signaling in the basal ganglia](https://doi.org/10.1016/j.tins.2020.06.012)
[Long-term potentiation molecular mechanisms](https://doi.org/10.1016/j.neuroscience.2020.01.012)
External Links
[NCBI Gene - PRKACG](https://www.ncbi.nlm.nih.gov/gene/55837)
[UniProt - P22694](https://www.uniprot.org/uniprot/P22694)
[PubMed - PRKACG](https://pubmed.ncbi.nlm.nih.gov/?term=PRKACG+neurodegeneration)
[KEGG cAMP Signaling Pathway](https://www.genome.jp/kegg/pathway/map04024) Show full description